Drug Class: Inhaled Corticosteroid (ICS) + Long-Acting Beta-2 Agonist (LABA) Combination | Form: Dry Powder Inhalation Rotacap (Rotahaler/Revolizer) | Prescription Status: Prescription Only (Rx) — DRAP Registered
What is Combivair 400/6mcg Rotacap? Combivair 400/6mcg contains Budesonide 400mcg and Formoterol Fumarate 6mcg in a dry powder inhalation rotacap — combining high-dose inhaled corticosteroid with moderate bronchodilation in a single inhalation device. The high 400mcg Budesonide dose provides intensive airway anti-inflammatory control suitable for moderate to severe persistent asthma where lower ICS doses have proven insufficient — while the conservative 6mcg Formoterol dose delivers effective 12-hour bronchodilation with a more cautious cardiovascular stimulation profile than the higher 12mcg Formoterol dose. This particular strength combination makes Combivair 400/6mcg uniquely positioned for patients requiring strong steroid anti-inflammatory control without maximum LABA bronchodilator exposure. Like all ICS/LABA combinations it is a daily controller medicine — never a rescue inhaler — and must be used consistently every day under pulmonologist supervision with a separate fast-acting reliever inhaler always available for acute episodes.
What is Combivair 400/6mcg Rotacap Used For?
- Moderate to severe persistent asthma — high-dose ICS control with moderate LABA bronchodilation (دمہ کا طویل مدتی علاج)
- COPD symptomatic management — reducing breathlessness, wheeze, and exacerbation frequency (سی او پی ڈی کی علامات کا علاج)
- Asthma inadequately controlled on lower dose ICS/LABA combinations — step-up therapy requiring stronger steroid coverage
- Prevention of asthma exacerbations — reducing frequency of severe attacks requiring oral steroids (دمہ کے شدید دوروں کی روک تھام)
- COPD with frequent exacerbations — combined anti-inflammatory and bronchodilator maintenance
- Asthma with significant airway inflammation — where high-dose Budesonide is specifically indicated
How Does it Work? Budesonide 400mcg acts locally within the airway mucosa at high therapeutic concentration — suppressing eosinophilic inflammation, reducing inflammatory cytokine production, decreasing mucus hypersecretion, and lowering bronchial hyper-responsiveness that causes asthma symptoms. At this higher dose the anti-inflammatory effect is more complete and sustained — providing better control of severe airway inflammation than lower Budesonide strengths. Formoterol Fumarate 6mcg selectively stimulates beta-2 adrenergic receptors in airway smooth muscle — producing rapid onset bronchodilation within 1 to 3 minutes that is sustained for up to 12 hours per inhalation. The 6mcg dose provides clinically effective bronchodilation while producing less beta-2 mediated cardiovascular stimulation — tremor, palpitations, and tachycardia — than the higher 12mcg dose, making it preferable where strong steroid coverage is the primary therapeutic goal.
Dosage and Administration
⚠️ For inhalation only — never swallow rotacaps. Use only with Rotahaler or Revolizer device as demonstrated by doctor or pharmacist. This is a controller inhaler — never use for sudden acute breathing attacks. Always carry a separate fast-acting reliever inhaler such as Salbutamol. Rinse mouth thoroughly with water and swallow after every single inhalation — prevents oral thrush from high-dose inhaled Budesonide.
| Indication | Usual Adult Dose | Frequency | Notes |
|---|---|---|---|
| Moderate to severe asthma | 1 rotacap (400/6mcg) | Twice daily | Morning and evening — consistent timing |
| COPD symptomatic management | 1 rotacap (400/6mcg) | Twice daily | Regular daily use essential |
| Step-up asthma therapy | 1 rotacap (400/6mcg) | Twice daily | Under pulmonologist supervision |
Active Ingredients
| Ingredient | Strength per Rotacap |
|---|---|
| Budesonide | 400mcg |
| Formoterol Fumarate | 6mcg |
Who Should NOT Use Combivair 400/6mcg Rotacap?
- Allergy to Budesonide, Formoterol, lactose, or any component of the rotacap
- Acute severe asthma attack or sudden bronchospasm — use fast-acting reliever instead
- Active untreated pulmonary tuberculosis
- Severe uncontrolled cardiovascular disease or significant cardiac arrhythmia
- Significant hypokalaemia — low blood potassium
- Children under 6 years — not established for this age group
- Pregnancy — consult pulmonologist before use; uncontrolled asthma in pregnancy is more dangerous than appropriately treated asthma
Side Effects
Common: Oral thrush — white patches in mouth from high-dose inhaled Budesonide (منہ میں سفید دھبے — ہر بار منہ کو پانی سے اچھی طرح کلی کریں اور پانی نگل لیں), hoarse voice, mild throat irritation, mild headache, mild tremor or palpitations from Formoterol component — usually mild and temporary at 6mcg dose.
Serious — Stop and seek emergency help immediately: Paradoxical bronchospasm — sudden worsening of wheezing and breathing difficulty immediately after inhalation (سانس لینے میں اچانک مشکل — فوری ہسپتال جائیں), severe allergic reaction — sudden swelling of face or throat with difficulty breathing (فوری مدد لیں), significant hypokalaemia — severe muscle weakness and irregular heartbeat from combined high-dose steroid and LABA effect (پٹھوں کی کمزوری — فوری ڈاکٹر کو بتائیں), systemic steroid effects with very prolonged high-dose use — easy bruising, adrenal suppression, worsening diabetes or blood pressure, reduced bone density, significant worsening of glaucoma.
Drug Interactions
| Medicine | Interaction |
|---|---|
| Beta-blockers (Atenolol, Propranolol) | Directly oppose Formoterol bronchodilation — avoid in asthma; cardioselective beta-blockers only with extreme caution |
| QT-prolonging medicines | Formoterol may prolong QT interval — increased arrhythmia risk with combination |
| Other beta-2 agonists (Salbutamol) | Additive cardiovascular effects — use reliever only when genuinely needed for acute symptoms |
| Diuretics (Furosemide, Thiazides) | Increase hypokalaemia risk — particularly significant with high-dose Budesonide 400mcg combination |
| Ketoconazole / Itraconazole | Significantly increase systemic Budesonide exposure at 400mcg — increased steroid side effect risk; avoid combination |
| Oral corticosteroids (Prednisolone) | Additive systemic steroid effects with high-dose inhaled Budesonide — monitor for adrenal suppression |
| MAO inhibitors / Tricyclic antidepressants | Increased cardiovascular risk from Formoterol component |
| Xanthines (Theophylline) | Additive hypokalaemia and cardiovascular stimulation risk |
Storage: Store below 25°C in a cool, dry place. Protect from moisture and direct sunlight. Keep rotacaps in original blister packaging until immediately before use — moisture immediately destroys dry powder formulation. Never store loose rotacaps outside blister. Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں). Do not use after expiry date.
FAQs
Q: What is the difference between Combivair 400/6mcg and Combivair or Venticort 400/12mcg formulations? Both contain the same high 400mcg Budesonide dose — the difference is Formoterol strength. The 400/6mcg combination provides strong anti-inflammatory control with moderate bronchodilation and less cardiovascular stimulation — preferred when intensive steroid coverage is the primary need. The 400/12mcg combination provides the same steroid dose with double the bronchodilation — used when both maximum anti-inflammatory and maximum bronchodilatory effects are simultaneously required.
Q: Why is mouth rinsing especially important after Combivair 400/6mcg compared to lower dose ICS combinations? The higher 400mcg Budesonide dose deposits more inhaled steroid in the mouth and throat than lower strength formulations — significantly increasing the risk of oral thrush and hoarseness if mouth rinsing is neglected. Thorough rinsing with water and swallowing after every single inhalation is non-negotiable at this higher steroid dose and must never be skipped.
Q: Can I use Combivair 400/6mcg rotacap as a rescue inhaler during an acute asthma attack? Absolutely not — Combivair is a daily controller inhaler only. During acute breathlessness always use your prescribed fast-acting reliever inhaler such as Salbutamol immediately. If symptoms do not improve rapidly seek emergency medical help without delay — never rely on a controller inhaler for acute attack management.
Medical Disclaimer: This information is for general awareness only and does not replace medical advice. Always consult a qualified doctor or pharmacist before taking any prescription medicine.